Scientists First to Track Joint Cartilage Development in Humans

Stem cell researchers from UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.

Transforming Medicine: An Evening with UCLA Stem Cell Scientists

 An Evening with UCLA Stem Cell Scientists"

Tuesday | October 22, 2013

6.30PM - 8.30PM
Ronald Reagan Medical Center
Tamkin Auditorium (B-130)
757 Westwood Plaza

Four UCLA Researchers Receive CIRM Early Translational Grants

Four prominent researchers from UCLA’s Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational research awards totaling approximately $13 million from the California Institute for Regenerative Medicine (CIRM) the state stem cell agency. The UCLA researchers received four of the 12 total awards; no other applicant institution received more than one award.

Researcher Wins Prestigious McCullough and Till Award

Dr. Hanna Mikkola

Dr. Hanna Mikkola, member of the UCLA Eli & Edythe Broad Center for Regenerative Medicine & Stem Cell Research and an associate professor of molecular, cell, and developmental biology in the life sciences has been named the 2013 recipient of the McCullough and Till Award by the Society for Hematology and Stem Cells, also known as the ISEH.

Gene Therapy for Sickle Cell Disease Advances Toward Clinical Trials

Dr. Donald Kohn and colleagues at the UCLA Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research successfully established the foundation for a gene therapy approach to treat sickle cell disease (SCD). Using patients own hematopoietic (blood producing) stem cells, Kohn introduced an anti-sickling gene into the stem cells to capitalize on their self-renewing potential that will create for the patients a continual source of healthy red blood cells that do not sickle.

Researchers Move Toward Treatments for Rare Genetic Nerve Disease

Researchers Develop New Method for Purifying Stem Cells for Treatment

Stem Cell Center researchers led by Drs. Carla Koehler and Michael Teitell discovered a new agent that may be useful in strategies to remove pluripotent stem cells that fail-to-differentiate from their progeny, tissue-specific cells, potentially resulting in safer therapies for patients. The study was published online ahead of press today in Developmental Cell.

UCLA Scientist Wins CIRM's Elevator Speech Challenge

Stem Cell Researcher Receives Stem Cell “Bank” Initiative Grant

Researchers Monitor T Cell Function to Improve Melanoma Treatment

Pages